Prevalent and Incident Tuberculosis Are Independent Risk Factors for Mortality among Patients Accessing Antiretroviral Therapy in South Africa

被引:48
|
作者
Gupta, Ankur [1 ]
Wood, Robin [2 ]
Kaplan, Richard [2 ]
Bekker, Linda-Gail [2 ]
Lawn, Stephen D. [1 ,2 ]
机构
[1] London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England
[2] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa
来源
PLOS ONE | 2013年 / 8卷 / 02期
基金
美国国家卫生研究院; 英国惠康基金;
关键词
HIV-ASSOCIATED TUBERCULOSIS; IMMUNE RECONSTITUTION DISEASE; SUB-SAHARAN AFRICA; PULMONARY TUBERCULOSIS; TREATMENT PROGRAM; INFECTED PATIENTS; EARLY OUTCOMES; RURAL UGANDA; ADULTS; DETERMINANTS;
D O I
10.1371/journal.pone.0055824
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Patients with prevalent or incident tuberculosis (TB) in antiretroviral treatment (ART) programmes in sub-Saharan Africa have high mortality risk. However, published data are contradictory as to whether TB is a risk factor for mortality that is independent of CD4 cell counts and other patient characteristics. Methods/Findings: This observational ART cohort study was based in Cape Town, South Africa. Deaths from all causes were ascertained among patients receiving ART for up to 8 years. TB diagnoses and 4-monthly CD4 cell counts were recorded. Mortality rates were calculated and Poisson regression models were used to calculate incidence rate ratios (IRR) and identify risk factors for mortality. Of 1544 patients starting ART, 464 patients had prevalent TB at baseline and 424 developed incident TB during a median of 5.0 years follow-up. Most TB diagnoses (73.6%) were culture-confirmed. A total of 208 (13.5%) patients died during ART and mortality rates were 8.84 deaths/100 person-years during the first year of ART and decreased to 1.14 deaths/100 person-years after 5 years. In multivariate analyses adjusted for baseline and time-updated risk factors, both prevalent and incident TB were independent risk factors for mortality (IRR 1.7 [95% CI, 1.2-2.3] and 2.7 [95% CI, 1.9-3.8], respectively). Adjusted mortality risks were higher in the first 6 months of ART for those with prevalent TB at baseline (IRR 2.33; 95% CI, 1.5-3.5) and within the 6 months following diagnoses of incident TB (IRR 3.8; 95% CI, 2.6-5.7). Conclusions: Prevalent TB at baseline and incident TB during ART were strongly associated with increased mortality risk. This effect was time-dependent, suggesting that TB and mortality are likely to be causally related and that TB is not simply an epiphenomenon among highly immunocompromised patients. Strategies to rapidly diagnose, treat and prevent TB prior to and during ART urgently need to be implemented.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Factors associated with mortality among patients with candidaemia in South Africa, 2012
    Fortuin-de Smidt, M. C.
    Meiring, S.
    Mpembe, R.
    Kularatane, R.
    Govender, N.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 288 - 288
  • [32] High Rates of Tuberculosis in Patients Accessing HAART in Rural South Africa
    Naidoo, Kogieleum
    Karim, Quarraisha Abdool
    Bhushan, Ambika
    Naidoo, Kasavan
    Yende-Zuma, Nonhlanhla
    Mchunu, Patricia K.
    Frohlich, Janet
    Karim, Farina
    Upfold, Michele
    Kocheleff, Paul
    Karim, Salim S. Abdool
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (04) : 438 - 446
  • [33] Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa
    Fielding, Katherine
    Koba, Ai
    Grant, Alison D.
    Charalambous, Salome
    Day, John
    Spak, Cedric
    Wald, Anna
    Huang, Meei-Li
    Corey, Lawrence
    Churchyard, Gavin J.
    PLOS ONE, 2011, 6 (10):
  • [34] Incidence of and risk factors for tuberculosis among people with HIV on antiretroviral therapy in the United Kingdom
    van Halsema, Clare L.
    Okhai, Hajra
    Hill, Teresa
    Sabin, Caroline A.
    AIDS, 2020, 34 (12) : 1813 - 1821
  • [35] Incidence and Risk Factors of Tuberculosis among Children Receiving Antiretroviral Therapy in Northwest, Ethiopia
    Endalew, Getaneh
    Beyene, Melkamu Bedimo
    Kassie, Ayalew
    Wassie, Gizachew Tadesse
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2025, 70
  • [36] Reducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa
    Hoffmann, Christopher J.
    Fielding, Katherine L.
    Charalambous, Salome
    Innes, Craig
    Chaisson, Richard E.
    Grant, Alison D.
    Churchyard, Gavin J.
    AIDS, 2010, 24 (11) : 1709 - 1716
  • [37] Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy
    Jabs, DA
    Holbrook, JT
    Van Natta, ML
    Clark, R
    Jacobson, MA
    Kempen, JH
    Murphy, RL
    OPHTHALMOLOGY, 2005, 112 (05) : 771 - 779
  • [38] Causes of Death and Risk Factors for Mortality among HIV-Infected Patients Receiving Antiretroviral Therapy in Korea
    Lee, Sun Hee
    Kim, Kye-Hyung
    Lee, Seung Geun
    Cho, Heerim
    Chen, Dong Hwan
    Chung, Joo Seop
    Kwak, Ihm Soo
    Cho, Goon Jae
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2013, 28 (07) : 990 - 997
  • [39] Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa
    Adeniyi, Oladele Vincent
    Ajayi, Anthony Idowu
    Ter Goon, Daniel
    Owolabi, Eyitayo Omolara
    Eboh, Alfred
    Lambert, John
    BMC INFECTIOUS DISEASES, 2018, 18
  • [40] Factors predicting retention among people accessing outpatient methadone maintenance therapy in Tshwane, South Africa
    Gloeck, Natasha Rachel
    Harris, Bernice
    Webb, Elizabeth
    Scheibe, Andrew
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50